1. Home
  2. MDGL vs SWK Comparison

MDGL vs SWK Comparison

Compare MDGL & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • SWK
  • Stock Information
  • Founded
  • MDGL 2011
  • SWK 1843
  • Country
  • MDGL United States
  • SWK United States
  • Employees
  • MDGL N/A
  • SWK N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • SWK Industrial Machinery/Components
  • Sector
  • MDGL Health Care
  • SWK Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • SWK Nasdaq
  • Market Cap
  • MDGL 9.6B
  • SWK 10.5B
  • IPO Year
  • MDGL N/A
  • SWK N/A
  • Fundamental
  • Price
  • MDGL $530.11
  • SWK $68.24
  • Analyst Decision
  • MDGL Strong Buy
  • SWK Buy
  • Analyst Count
  • MDGL 13
  • SWK 9
  • Target Price
  • MDGL $523.92
  • SWK $92.25
  • AVG Volume (30 Days)
  • MDGL 409.9K
  • SWK 1.9M
  • Earning Date
  • MDGL 11-04-2025
  • SWK 11-04-2025
  • Dividend Yield
  • MDGL N/A
  • SWK 4.87%
  • EPS Growth
  • MDGL N/A
  • SWK N/A
  • EPS
  • MDGL N/A
  • SWK 2.90
  • Revenue
  • MDGL $740,640,000.00
  • SWK $15,166,300,000.00
  • Revenue This Year
  • MDGL $395.75
  • SWK $0.46
  • Revenue Next Year
  • MDGL $65.73
  • SWK $3.65
  • P/E Ratio
  • MDGL N/A
  • SWK $23.56
  • Revenue Growth
  • MDGL 864.21
  • SWK N/A
  • 52 Week Low
  • MDGL $265.00
  • SWK $53.91
  • 52 Week High
  • MDGL $544.25
  • SWK $93.63
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 74.00
  • SWK 46.21
  • Support Level
  • MDGL $399.00
  • SWK $66.50
  • Resistance Level
  • MDGL $544.25
  • SWK $68.98
  • Average True Range (ATR)
  • MDGL 27.05
  • SWK 2.38
  • MACD
  • MDGL 11.07
  • SWK 0.07
  • Stochastic Oscillator
  • MDGL 91.20
  • SWK 37.43

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About SWK Stanley Black & Decker Inc.

Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.

Share on Social Networks: